Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
256
-
Total 13F shares, excl. options
-
35M
-
Shares change
-
-1.19M
-
Total reported value, excl. options
-
$4.75B
-
Value change
-
-$136M
-
Put/Call ratio
-
1.6
-
Number of buys
-
126
-
Number of sells
-
-115
-
Price
-
$135.89
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q2 2023
290 filings reported holding CNMD - CONMED Corp - Common Stock as of Q2 2023.
CONMED Corp - Common Stock (CNMD) has 256 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35M shares
.
Largest 10 shareholders include BlackRock Inc. (4.97M shares), VANGUARD GROUP INC (3.44M shares), Capital Research Global Investors (2.47M shares), EARNEST PARTNERS LLC (2.22M shares), STATE STREET CORP (1.17M shares), BANK OF AMERICA CORP /DE/ (1.09M shares), AMERIPRISE FINANCIAL INC (1.05M shares), JPMORGAN CHASE & CO (985K shares), Champlain Investment Partners, LLC (944K shares), and LOOMIS SAYLES & CO L P (798K shares).
This table shows the top 256 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.